Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2012 Jul;194(13):3336–3342. doi: 10.1128/JB.00253-12

Rrp2, a Prokaryotic Enhancer-Like Binding Protein, Is Essential for Viability of Borrelia burgdorferi

Ashley M Groshong a, Nora E Gibbons a, X Frank Yang b, Jon S Blevins a,
PMCID: PMC3434732  PMID: 22544267

Abstract

The Lyme disease spirochete, Borrelia burgdorferi, exists in two diverse niches (i.e., an arthropod tick vector and mammalian host) during its enzootic life cycle. To effectively adapt to these unique environments, the bacterium alters the expression of numerous genes, including several major outer surface (lipo)proteins that are required for infection and transmission. An enhancer-binding protein (EBP), known as Rrp2, is one identified activator of the RpoN/RpoS alternative sigma factor cascade. Because initial efforts to generate an rrp2 deletion strain were unsuccessful, the role of Rrp2 in the activation of the RpoN/RpoS pathway was first defined using a strain of B. burgdorferi carrying an rrp2 point mutant that was defective in its ability to activate RpoN-dependent transcription. The fact that subsequent attempts to disrupt rrp2 have also been unsuccessful has led investigators to hypothesize that Rrp2 has other undefined functions which are essential for B. burgdorferi survival and independent of its EBP function. We used a lac-based inducible expression system to generate a conditional rrp2 mutant in virulent B. burgdorferi. In this strain, an isopropyl-β-d-thiogalactopyranoside-inducible copy of the rrp2 gene is expressed in trans from a borrelial shuttle vector. We found that the chromosomal copy of rrp2 could be inactivated only when rrp2 was induced, and the maintenance of rrp2 expression was required for the growth of the mutants. In addition, the overexpression of rrp2 is detrimental to B. burgdorferi growth in a manner that is independent of the RpoN/RpoS pathway. These studies provide the first direct evidence that rrp2 is an essential gene in B. burgdorferi.

INTRODUCTION

During its natural enzootic life cycle, Borrelia burgdorferi transitions between an arthropod vector and a mammalian host (36). To adapt to the distinct environments represented within the tick and mammal, spirochetes must undergo significant changes in gene expression that are hallmarked by the inverse regulation of two major outer surface (lipo)proteins (Osps), OspA and OspC (1, 13, 14, 18, 27, 30, 33, 34, 38). The reciprocal regulation of ospA and ospC is mediated by an alternative sigma factor cascade in which one alternative sigma factor (RpoN, σN) controls the expression of a second alternative sigma factor (RpoS, σS) (5, 911, 16, 20, 28, 35, 42). Specifically, RpoN mediates rpoS expression at the level of transcription via a canonical −24/−12 RpoN-dependent promoter located upstream of rpoS (35). RpoS then serves to activate the transcription of ospC and other potential virulence- or transmission-associated proteins, such as decorin-binding protein A (DbpA), BBA52, and BBA07 (11, 15, 20, 28, 42). The Hk1-Rrp1 cyclic-di-GMP regulatory network has also been identified as an important regulator of numerous cellular processes in B. burgdorferi and has been shown to be critical for maximal dissemination in mammals and acquisition/survival within ticks (12, 19, 24, 32).

One of the key characteristics of RpoN-dependent gene transcription is the requirement for an additional activator known as an enhancer-binding protein (EBP) (8, 26, 37). The genome of B. burgdorferi encodes one such activator (17), rrp2 (bb0763), which is homologous to the NtrC family of EBPs (41). NtrC EBPs contain an amino-terminal response regulator receiver domain, a central RpoN activation domain, and a carboxy-terminal DNA-binding domain (26). To activate RpoN-dependent transcription, the N-terminal domain of Rrp2 is presumed to be phosphorylated at the D52 residue in the amino-terminal domain (41). Phosphorylated Rrp2 activates RpoN-dependent transcription by binding to the RpoN-RNA polymerase holoenzyme and hydrolyzing ATP to provide the energy necessary to form the open promoter complex (26, 31, 37). Because attempts to generate an rrp2 deletion strain were unsuccessful, the role of Rrp2 in activating the RpoN/RpoS pathway in B. burgdorferi was initially demonstrated by targeting its ATPase activity (41). Specifically, a B. burgdorferi strain was generated that carried a point mutation in rrp2 that replaced one of the key residues responsible for binding ATP [i.e., Rrp2(G239C)]. The Rrp2(G239C) mutant strain was viable; however, it was unable to activate the RpoN/RpoS pathway and subsequently was incapable of expressing known rpoS-regulated outer surface proteins (6, 28, 41). Therefore, Rrp2 has been identified as a key activator of the RpoN/RpoS pathway.

While prior studies have successfully defined the importance of Rrp2 in B. burgdorferi gene regulation (6, 9, 28, 41), they have also revealed several enigmatic features that distinguish it from prototypical EBPs found in other bacterial species. First, data suggest that Rrp2 activates RpoN-dependent transcription in the absence of apparent upstream enhancer elements that commonly are associated with other EBPs (5, 9). While this finding is not unique to B. burgdorferi (2, 7, 22), it distinguishes Rrp2 from the prototypical members of the NtrC family of EBPs (8). Second, despite numerous attempts to create an rrp2 deletion mutant in B. burgdorferi (5, 9, 41), the only rrp2 mutant strain that has been successfully generated is the Rrp2(G239C) mutant (41). This inability to produce an rrp2 deletion mutant has led many investigators to hypothesize that Rrp2 has other undefined functions which are essential for B. burgdorferi growth but independent of its EBP function (5, 9, 41). To test this hypothesis, we generated a conditional rrp2 mutant in virulent B. burgdorferi using a shuttle vector-based lac repressor/operator-inducible expression system to express rrp2 in trans (4). Using this approach, we found that we were only able to inactivate rrp2 in a strain of B. burgdorferi expressing the inducible copy of rrp2 carried by the shuttle vector. In addition, the induction and maintenance of rrp2 expression were required for the growth of the mutant strains in which the native copy of rrp2 was deleted. During these studies, it was also found that the overexpression of rrp2 was detrimental to B. burgdorferi growth by a mechanism that is independent of rpoN and rpoS. These data provide the first definitive evidence that rrp2 is necessary for the viability of B. burgdorferi.

MATERIALS AND METHODS

Bacterial strains and culture conditions.

All strains and plasmids used in this study are described in Table 1. Infectious, low-passage B. burgdorferi strain 297 (Bb297) was used for these studies (21). Escherichia coli strain TOP10F′ (Invitrogen, Carlsbad, CA) was used as a cloning host. E. coli transformants were selected in Luria-Bertani medium supplemented with 100 μg/ml of ampicillin, 100 μg/ml of spectinomycin, or 50 μg/ml of kanamycin. Unless noted otherwise, B. burgdorferi was grown in Barbour-Stoenner-Kelley-II (BSK-II) medium at 37°C with 3 to 5% CO2 and 150 μg/ml of streptomycin or 150 μg/ml of kanamycin when appropriate (29).

Table 1.

Strains and plasmids used in this study

Strain or plasmid Description Source or reference
Strains
    E. coli TOP10F′ F′[lacIq Tn10(Tetr)] mcrA Δ(mrr-hsdRMS-mcrBC) ϕ80lacZΔM15 ΔlacX74 recA1 araΔ139 Δ(ara-leu)7697 galU galK rpsL (Strr) endA1 nupG Invitrogen
    B. burgdorferi
        Bb297 Strain 297; infectious, human spinal fluid isolate 21
        BbiRrp2 Bb297 transformed with piRrp2; Strepr This study
        BbiRrp2-Δrrp2 BbiRrp2 with rrp2 interrupted by Kan marker; Strepr Kanr This study
        BbJSB18-B2 Bb297 rpoN::PflgB-aadA mutant; Strepr 35
        BbJSB19-A7B Bb297 rpoS::PflgB-aadA mutant; Strepr 28
        BbΔrpoN/piRrp2 BbJSB18-B2 transformed with piRrp2(Kan); Strepr Kanr This study
        BbΔrpoS/piRrp2 BbJSB19-A7B transformed with piRrp2(Kan); Strepr Kanr This study
Plasmids
    pGEM-T Easy TA cloning vector; Ampr Promega
    pJSB104 Shuttle vector with IPTG-inducible luciferase; Spec/Strepr 4
    pJSB275 pJSB104 lacking the NdeI in the resistance marker; Spec/Strepr This study
    piRrp2 pJSB275 with Bbluc+ replaced with rrp2 ORF; Spec/Strepr This study
    pJSB194 Shuttle vector with IPTG-inducible BptA; Kanr 4
    piRrp2(Kan) pJSB194 with BptA replaced with rrp2 ORF; Kanr This study
    pJSB386A pGEM-T Easy rrp2::Kan insertional activation construct; Kanr This study

Generation of the inducible rrp2 shuttle vectors.

The rrp2 open reading frame (ORF) was PCR amplified with Primestar HS DNA polymerase (TaKaRa, Madison, WI) using Bb297 genomic DNA as a template and primers 297-Rrp2 ORF/NdeI-5′ and 297-Rrp2 ORF/HindIII-3′ (Table 2), which introduced NdeI and HindIII restriction sites to the 5′ and 3′ ends of the ORF, respectively. The PCR fragment was TA cloned into pGEM-T Easy (Promega Corp., Madison, WI), verified by DNA sequencing, excised with NdeI and HindIII, and ligated into a modified derivative of pJSB104 (i.e., pJSB275) that had been digested with the same restriction enzymes (4). pJSB104 and pJSB275 are borrelial shuttle vectors that contain a codon-adapted lacI repressor transcribed from the PflaB promoter and an isopropyl-β-d-thiogalactopyranoside (IPTG)-inducible T5 promoter derived from pQE30. To facilitate the inducible expression of a gene, the ORF for the gene of interest is fused downstream of the T5 promoter. The resulting shuttle vector carrying the inducible rrp2 was designated piRrp2 (Fig. 1A). Because the mutations in our previously characterized Bb297 rpoS and rpoN mutants were marked with a Strepr marker (28, 35), the PflgB-aadA Strepr marker in piRrp2 had to be replaced with an aph[3′]-IIIa kanamycin resistance (Kanr) marker (4). This construct, designated piRrp2(Kan), was generated by exchanging the NdeI/HindIII-flanked bptA ORF in pJSB194 (4) for the NdeI/HindIII-flanked rrp2 ORF described above.

Table 2.

Oligonucleotide primers used in this study

Primer designation Sequencea
297-Rrp2 ORF/NdeI-5′ CACATATGAGCAAAATACTTGTAGCTG
297-Rrp2 ORF/HindIII-3′ CAAGCTTACTATTGATCAATATTATATTCG
Rrp2-F1-5′ GGATGGCAGTCCGGCATTGCTACT
Rrp2-F1/AscI-3′ GGCGCGCCTTGAAAGCGCATTAATATTATCAAAAGG
Rrp2-F2/AscI-5′ GGCGCGCCTTCATCCTCAAGATAAGTAGC
Rrp2-F2/BssHII-3′ GCGCGCTGAAGGAATCATTGTACTTGAC
5′-KanT7term/AscI GGCGCGCCTAATACCCGAGCTTCAAGGAAG
3′-KanT7term/AscI GGCGCGCCAGATCCGGATATAGTTCCTCCTTTC
Rrp2 diag 5′ GTAAGGCCAGGCTCTGTAGCCAGC
Rrp2 diag 3′ GTGGAAAGCAAAGAAGGCAAAGGCAC
Rrp2 seq 3F GCTTTCAGAAAGTGCTGCGCA
aphI-seq-out-3′ TCGTCTCGCTCAGGCGCAATC
priAH27 CGGGTCATATTTTTCAGCAGCTC
priAH131 GCAGGACAAATACAAAGAGGCAATGC
priAH59 GCTCCACCAACAGAGCTAAAAAGC
priAH61 GCAAAGTGGTTAATCGAATCCCTACG
a

Relevant restriction sites are indicated in bold.

Fig 1.

Fig 1

piRrp2 inducible shuttle vector and immunoblot confirmation of BbiRrp2. (A) To create piRrp2, the rrp2 ORF was amplified from Bb297 and cloned into a derivative of pJSB104. (B) Immunoblot analysis of Rrp2, OspC, and FlaB in wild-type Bb297 and BbiRrp2. Cultures were grown to the mid-exponential phase and either left untreated or supplemented with 1 mM IPTG. Antibodies used to detect the respective proteins are indicated at the right. Values at the left denote relevant molecular masses (kDa) of the standard (MW).

Construction of the rrp2::Kan mutation vector.

Regions of DNA flanking the rrp2 ORF were amplified using primers that introduced an AscI restriction site on the 3′ end of a 1.2-kb upstream flanking region, as well as a 5′ AscI site and a 3′ BssHII site on a 1.1-kb downstream flanking region (Table 2). These regions were amplified using Primestar HS DNA polymerase and TA cloned into pGEM-T Easy. To ligate the two flanking regions, the downstream flanking fragment was excised using BssHII and ligated into the vector containing the upstream region that was linearized with AscI. A Kanr marker, designated flgBp-aphI-T7t, was provided by Scott Samuels at the University of Montana. The flgBp-aphI-T7t cassette was PCR amplified using Primestar HS DNA polymerase and primers 5′-KanT7term/AscI and 3′-KanT7term/AscI (Table 2), which introduced AscI sites at the ends of the resistance marker. The Kanr marker was then ligated into the unique AscI restriction site at the junction between the two flanking regions. The final mutagenesis construct, designated pJSB386A, contained a Kanr marker replacing a large internal region of the rrp2 ORF between bp 75 and 1104.

Transformation of piRrp2 and piRrp2(Kan) into B. burgdorferi.

The transformation of B. burgdorferi with piRrp2 was carried out as described by Yang et al. (43). Strepr clones recovered after the electroporation of Bb297 with piRrp2 were designated BbiRrp2 (Table 1). piRrp2(Kan) was electroporated into the Bb297 rpoS and rpoN mutants to generate BbΔrpoS/piRrp2 and BbΔrpoN/piRrp2, respectively (Table 1). The PCR confirmation of the rpoS (priAH27 and priAH131) and rpoN (priAH59 and priAH60) mutations was performed as described by Hubner et al. (20). The PCR-based profiling of endogenous borrelial plasmids in transformants was performed as described by Blevins et al. (3).

Transformation of the rrp2::Kan mutagenesis construct into BbiRrp2.

The pJSB386A construct was electroporated into BbiRrp2 as described above, and transformants were recovered in streptomycin, kanamycin, and 0.05 mM IPTG. Interruption of the native copy of rrp2 by the Kanr marker was confirmed by PCR with the following primer pairs (Table 2): Rrp2 diag 5′ and Rrp2 diag 3′ (P1 and P3), Rrp2 seq 3F and Rrp2 diag 3′ (P2 and P3), and Rrp2-F2/BssHII-3′ and aphI-seq-out-3′ (P5 and P4). Confirmed rrp2 conditional mutants were designated BbiRrp2-Δrrp2. The PCR-based profiling of endogenous borrelial plasmids in transformants was performed as described by Blevins et al. (3).

IPTG induction of rrp2 expression.

To confirm rrp2 expression, cultures were grown to the mid-log phase of growth (∼1 × 107 spirochetes/ml), at which time they were divided; 1 mM IPTG was added to one portion, while the remainder was left untreated. Bacteria were collected at 24 h postinduction for immunoblot analysis. To confirm the pH-dependent activation of induced Rrp2, cultures were inoculated at an initial density of 1 × 103 bacteria/ml in BSK-II medium containing 0.05 mM IPTG that was adjusted to either pH 7.5 or 6.8. Bacteria were then collected at 7 days postinoculation (approximately 5 × 108 bacteria/ml) for immunoblot analysis.

Immunoblot analyses.

Immunoblotting was performed as described by Blevins et al. (5). For the colorimetric detection of Rrp2, FlaB, and OspC, 4-chloro-1-naphthol was used as the substrate. Antibodies and antisera used to detect Rrp2, FlaB, and OspC were described in prior studies (3, 4, 35). In all experiments, cell lysate from 1 × 107 bacteria was loaded in each gel lane. FlaB detection was included in all comparisons to confirm that equivalent concentrations of lysates were loaded. The All Blue Precision Plus molecular weight standard (Bio-Rad, Hercules, CA) was used for all immunoblots.

Growth curve analyses.

For growth curve analyses, strains were inoculated to an initial density of 1 × 103 bacteria/ml, and IPTG was added when necessary. Beginning at 3 days postinoculation, culture densities were determined daily by enumerating spirochetes using dark-field microscopy; 10 fields were counted per sample. To assess the effect of Rrp2 depletion on BbiRrp2-Δrrp2, cultures were inoculated as described above. When the culture reached the early exponential phase of growth (1 × 106 bacteria/ml), the spirochetes were collected by centrifugation and washed twice with sterile saline. The washed cell pellet was resuspended in BSK-II to a final density of 1.7 × 106 bacteria/ml. The culture was then divided into three portions and supplemented with either 0.05 or 1 mM IPTG or left untreated. Cell growth was monitored as described above. To assess Rrp2 production, bacteria were collected at 24, 48, and 72 h postdepletion for immunoblotting.

RESULTS AND DISCUSSION

Generation and characterization of the IPTG-inducible rrp2 strain.

Prior attempts by numerous investigators to generate a mutant of B. burgdorferi in which rrp2 is deleted have been unsuccessful (5, 9, 41). While these data suggest that rrp2 is essential for growth, it is also possible that recombination into this region is inefficient. However, Yang et al. (41) initially defined the RpoN-activating function of Rrp2 by replacing the native copy of rrp2 in the B. burgdorferi chromosome with an Rrp2(G239C) point mutant allele. Therefore, this inability to disrupt rrp2 is likely not due to reduced recombination frequency at this locus. To test whether rrp2 was indispensable, we generated a conditional rrp2 mutant in B. burgdorferi. To achieve this, the rrp2 ORF was cloned into a derivative of the previously described pJSB104 borrelial inducible expression vector (4). The resulting vector, designated piRrp2 (Fig. 1A), carries the rrp2 ORF fused to an IPTG-inducible promoter and a constitutively expressed lacI repressor that has been codon optimized to enhance expression in B. burgdorferi. piRrp2 was then transformed into wild-type Bb297 (21) to generate strain BbiRrp2 (Table 1). PCR-based plasmid profiling revealed that the endogenous plasmid profile of BbiRrp2 matched that of Bb297 (data not shown). To confirm that piRrp2 was functional in B. burgdorferi, a culture of BbiRrp2 was grown to the mid-exponential phase of growth, and IPTG was added to induce Rrp2 production. At 24 h postinduction, cells were collected and protein expression evaluated by immunoblotting (Fig. 1B). The production of Rrp2 was elevated in IPTG-treated cultures of BbiRrp2, whereas the treatment of wild-type Bb297 with IPTG did not affect Rrp2 levels (Fig. 1B). The induction of rrp2 in BbiRrp2 also resulted in increased levels of OspC (Fig. 1B). This is somewhat surprising, since BbiRrp2 was not cultivated under pH conditions to specifically trigger the Rrp2-mediated activation of RpoN (40). It is possible that a small proportion of Rrp2 is spontaneously phosphorylated during in vitro cultivation by small phosphodonors (e.g., Xu et al. demonstrated that acetyl phosphate can activate the Rrp2/RpoN/RpoS pathway [39]). Therefore, increasing the overall intracellular concentration of Rrp2 may serve to increase the level of this nonspecifically activated Rrp2 present in the spirochete. Nevertheless, these results suggest that Rrp2 expressed from piRrp2 is functional.

Generation and confirmation of the B. burgdorferi conditional rrp2 mutant.

To generate a conditional rrp2 mutant, the pJSB386A knockout construct was electroporated into BbiRrp2, and allelic exchange between pJSB386A and the chromosome disrupted the native copy of rrp2 with an aphI Kanr resistance marker (Fig. 2A). If rrp2 is essential, the Rrp2 expressed from piRrp2 should compensate for the loss of rrp2 in the chromosome. In agreement with prior studies (5, 9, 41), no Kanr clones were recovered following the electroporation of Bb297 with pJSB386A (data not shown). In contrast, Kanr transformants were readily obtained after the electroporation of BbiRrp2 with pJSB386A when cultures were supplemented with IPTG. PCR analyses of individual Kanr clones confirmed that the chromosomal copy of rrp2 was interrupted by aphI in these transformants (Fig. 2B). Thus, the resulting strain, BbiRrp2-Δrrp2, contains a disrupted chromosomal rrp2 and an intact copy of rrp2 under the control of an IPTG-inducible promoter. Further PCR-based plasmid profiling identified two clones with an endogenous plasmid profile matching that of Bb297 and BbiRrp2 (data not shown).

Fig 2.

Fig 2

Construction and characterization of the BbiRrp2-Δrrp2 mutant. (A) Diagram illustrating the strategy for inactivation of rrp2. pJSB386A, pertinent region of the suicide vector used to disrupt rrp2; WT, rrp2 and the flanking regions in the B. burgdorferi chromosome; Δrrp2, predicted genomic structure of the rrp2::Kan mutant. The solid black arrows denote relative positions of primers used for the PCR characterization of rrp2 mutants. (B) PCR confirmation of disruption of rrp2. Two individual clones of BbiRrp2 and BbiRrp2-Δrrp2 were screened. Oligonucleotide pairs used are designated to the right of each panel. P1 and P3 amplify across the inserted marker to generate different-sized amplicons, 1.6 kb (wild type) and 2.1 kb (Δrrp2). The P5 and P4 pair is specific for rrp2::Kan, and P2 and P3 only amplify a chromosomal copy of intact rrp2. Bb297, wild-type B. burgdorferi; H2O, negative control for amplification; pJSB386A, rrp2::Kan suicide vector used to interrupt rrp2. DNA size standards (MW), indicated to the left of the panel, are shown in kilobases. (C) Immunoblot analysis of Rrp2, OspC, and FlaB in Bb297 and BbiRrp2-Δrrp2 cultivated in vitro at pH 7.5 or 6.8. Antibodies used to detect the respective proteins are indicated at the right. Values at the left denote relevant molecular masses (kDa) of the standard (MW).

To confirm that Rrp2 expressed from piRrp2 was functional in BbiRrp2-Δrrp2, we assessed the activation of the RpoN/RpoS regulatory network in the mutant. To test this, BbiRrp2-Δrrp2 was grown at 37°C with IPTG to a high cell density in BSK-II medium, which had been adjusted to pH 6.8; these conditions are known to activate the Rrp2/RpoN/RpoS pathway of B. burgdorferi in vitro (40). An additional set of cultures was similarly grown in BSK-II at the standard pH of 7.5. Bb297 was cultivated under similar conditions as a control. When the cultures reached the stationary phase of growth, bacteria were collected for immunoblot analysis (Fig. 2C). In contrast to the bacteria cultivated at pH 7.5, which showed limited OspC production, increased OspC expression was observed in spirochetes from the pH 6.8 cultures. Slightly higher levels of OspC were also observed in pH 7.5 cultures of BbiRrp2-Δrrp2 than in cultures of Bb297. The elevated OspC levels in BbiRrp2-Δrrp2 may be due to a modest increase in Rrp2 concentration in the mutant strain (Fig. 2C). Regardless, these results showed the pH-dependent activation of the RpoN-RpoS pathway in BbiRrp2-Δrrp2, similarly to that observed in wild-type B. burgdorferi.

In vitro growth characteristics of the conditional rrp2 mutant.

To assess whether rrp2 is essential for B. burgdorferi growth, cultures of BbiRrp2-Δrrp2 were grown in the presence or absence of IPTG. A control culture of BbiRrp2 was similarly inoculated and treated. Starting at 3 days postinoculation, cell densities in each culture were enumerated daily using dark-field microscopy. While both BbiRrp2 and BbiRrp2-Δrrp2 grew similarly in the presence of IPTG, no measurable growth was detected at any of the time points measured in the culture of BbiRrp2-Δrrp2 from which IPTG was omitted (Fig. 3). These data provide the first definitive evidence that rrp2 is essential in B. burgdorferi.

Fig 3.

Fig 3

In vitro growth characteristics of the conditional rrp2 mutant. Cultures of BbiRrp2 and BbiRrp2-Δrrp2 were grown for 7 days in the presence (+ IPTG) or absence (− IPTG) of 0.05 mM IPTG. Values in the growth curves represent the mean cell counts ± standard deviations (SD) from two trials.

In the experiments described above, the essentiality of rrp2 was demonstrated by the inability of BbiRrp2-Δrrp2 to grow when inoculated into media lacking IPTG. If rrp2 is truly indispensable, the removal of inducer from an established culture of BbiRrp2-Δrrp2 should have a similar effect. To test this, a culture of BbiRrp2-Δrrp2 was grown to the early exponential growth phase in the presence of IPTG. Spirochetes were collected from the culture by centrifugation, washed with saline to remove inducer, and resuspended in fresh BSK-II medium to a final density of 1.7 × 106 bacteria/ml. One portion of the postwash culture remained untreated, while IPTG was added to a final concentration of 0.05 or 1 mM in the remaining two aliquots. Cell densities of each culture were monitored daily, and bacteria were collected for immunoblot analyses to assess Rrp2 levels. While there was a brief lag in cell growth immediately after the cells were washed, the BbiRrp2-Δrrp2 culture supplemented again with 0.05 mM IPTG reached the postexponential stage of growth at approximately 5 days after the depletion of the IPTG-treated culture (see Fig. 4A). This was similar to the growth rate observed with BbiRrp2-Δrrp2 (Fig. 3). Therefore, the process of washing and diluting the initial IPTG-treated BbiRrp2-Δrrp2 culture did not adversely affect cell growth and viability. During the first 3 days, there was a modest increase (approximately 1 log) in the bacterial density of the BbiRrp2-Δrrp2 culture from which IPTG was omitted (Fig. 4A). However, between days 2 and 3 the growth rate in the untreated culture was substantially lower than that observed in the 0.05 mM IPTG-treated culture. Moreover, the cell density began to decrease in the untreated culture on the fourth day posttreatment.

Fig 4.

Fig 4

Effect of removing inducer on growth of the conditional rrp2 mutant. A culture of BbiRrp2-Δrrp2 was grown with 0.05 mM IPTG to the early log phase. Cells were then washed to remove inducer and resuspended in media supplemented with various concentrations of IPTG. (A) Bacterial growth in each culture was assessed, and the values in the graphs represent the mean cell counts ± SD. Duplicate growth curves were performed with equivalent results; data from a representative study are shown. Values shown in the graph legend refer to the IPTG concentration added to the respective cultures. (B) Immunoblot analysis of Rrp2 production in IPTG-depleted BbiRrp2-Δrrp2 cultures cultivated in the presence of different concentrations of inducer. Antibodies used to detect the respective proteins are indicated at the right. Values at the left denote relevant molecular masses (kDa) of the standard (MW).

During the first 3 days following depletion, immunoblot analysis was used to evaluate Rrp2 production (Fig. 4B). In the culture that did not receive IPTG, we were able to detect a very small amount of Rrp2 at the earliest time point, but Rrp2 was not evident at 48 and 72 h postdepletion. The treatment of the depleted BbiRrp2-Δrrp2 culture with 0.05 or 1 mM IPTG resulted in readily detectable levels of Rrp2. In addition, Rrp2 levels were higher in cultures that received 1 mM IPTG. These data confirm the hypothesis that the inability to inactivate rrp2 using classical allelic exchange was due to rrp2 being required for B. burgdorferi growth (5, 9, 41). Although this is not the first reported use of a conditional mutation system to identify essential genes in B. burgdorferi (25), this study confirms that our shuttle vector-based lac repressor/operator system is suitable for such an application.

Inhibition of B. burgdorferi growth in response to rrp2 overexpression.

An additional finding that came out of these studies was that the overexpression of rrp2 was detrimental to cell growth. The inhibition of bacterial growth in cultures treated with excess IPTG (e.g., 1 mM) was observed in both BbiRrp2 (data not shown) and BbiRrp2-Δrrp2 (Fig. 4A). It was noted that the induction of rrp2 in BbiRrp2 also results in the upregulation of OspC (Fig. 1B). Given that the overproduction of RpoS also negatively affects B. burgdorferi growth (A. M. Groshong and J. S. Blevins, unpublished results), it is possible that the growth inhibition following rrp2 overexpression is due to the activation of the RpoN/RpoS pathway. To test this, Bb297 rpoN and rpoS mutants were transformed with the piRrp2(Kan)-inducible rrp2 shuttle vector; confirmed transformants were designated BbΔrpoN/piRrp2 and BbΔrpoS/piRrp2. BbΔrpoN/piRrp2 and BbΔrpoS/piRrp2 were cultivated in the presence or absence of IPTG, and bacterial growth was monitored daily. BbΔrpoN/piRrp2 and BbΔrpoS/piRrp2 cultures grown without IPTG showed normal growth, whereas no growth was detected in the cultures supplemented with excess IPTG (Fig. 5A). The results with BbΔrpoN/piRrp2 and BbΔrpoS/piRrp2 were identical to those obtained with BbiRrp2 and BbiRrp2-Δrrp2 (data not shown and Fig. 4A). To confirm that the RpoN/RpoS regulatory network was not activated in BbΔrpoN/piRrp2 and BbΔrpoS/piRrp2, mutants were grown to the mid-exponential phase of growth and IPTG was added to induce rrp2 expression. At 24 h postinduction, protein expression was assessed by immunoblotting (Fig. 5B). As expected, IPTG-treated BbΔrpoN/piRrp2 and BbΔrpoS/piRrp2 did not express OspC. While the mechanism by which the overexpression of rrp2 inhibits B. burgdorferi growth is unknown, these data clearly demonstrate that growth inhibition arising from rrp2 overexpression is not a consequence of RpoN/RpoS activation.

Fig 5.

Fig 5

Effect of overexpression of rrp2 in rpoN and rpoS mutant backgrounds. Cultures of BbΔrpoN/piRrp2 and BbΔrpoS/piRrp2 were grown in the presence (+ IPTG) or absence (− IPTG) of 1 mM IPTG. (A) Bacterial growth in each culture was assessed, and the values in the graphs represent the mean cell counts ± SD from two trials. (B) To assess OspC levels following the induction of rrp2 with IPTG, cultures of BbiRrp2, BbΔrpoN/piRrp2, and BbΔrpoS/piRrp2 were grown to the mid-exponential phase and then either left untreated or supplemented with 1 mM IPTG. Antibodies used to detect the respective proteins are indicated at the right. Values at the left denote relevant molecular masses (kDa) of the standard (MW).

Summary and conclusions.

While we do not know the identity of the specific essential genes that are regulated by rrp2, the application of the inducible system will make it possible to identify genes which are differentially regulated in BbiRrp2-Δrrp2. We have shown that the BbiRrp2-Δrrp2 mutant can only grow in the presence of IPTG. Therefore, it is possible to wash the cells to remove IPTG so that we can assess gene expression changes when rrp2 is not expressed. The identity of the gene(s) whose expression is affected by rrp2 during overexpression also remains to be determined. Although the biological relevance of rrp2 overproduction is unknown, it would be interesting to determine whether genes that are responsible for growth inhibition when rrp2 is overexpressed represent the same group of rrp2-regulated genes that are required for B. burgdorferi growth. The ideal approach to identify genes whose expression is altered during rrp2 overexpression would be to utilize a strain in which the RpoN/RpoS pathway is inoperative, or to clone Rrp2(G239C) in an inducible expression construct and then assess changes in gene expression upon the induction of the point mutant in a wild-type B. burgdorferi background (41). Since EBPs such as rrp2 control the transcription of their target genes through rpoN, it is difficult to predict the mechanism by which the expression of the genes in this branch of rrp2-dependent regulation would be controlled. To date, no one has been able to confirm that Rrp2 interacts with a specific DNA sequence upstream of the RpoN-dependent promoter of rpoS (5, 9). This presumed lack of specificity could provide a potential for promiscuity in activating genes at the transcriptional level, but how rrp2-dependent activation would function in the absence of rpoN is unclear.

In conclusion, we have provided the first definitive evidence that rrp2 is essential in B. burgdorferi. The fact that the B. burgdorferi Rrp2(G239C) mutant described by Yang et al. (41) is unable to activate RpoN-dependent transcription but exhibits no growth defect suggests that the essential function that rrp2 serves is independent of its EBP activity. While there is evidence for at least one bacterial species in which RpoN is essential (e.g., Myxococcus xanthus) (23), this would mark the first demonstration of an NtrC family EBP serving a role, independent of its cognate EBP function, that is indispensable for bacterial viability, likely by controlling genes involved in cellular metabolism. Studies are under way to identify the rrp2-regulated gene products that contribute to borrelial growth and the manner by which their expression is regulated. Once these genes have been identified, we can begin to elucidate the mechanism by which Rrp2 controls genes independently of RpoN-mediated transcription.

ACKNOWLEDGMENTS

We thank Scott Samuels for providing the flgBp-aphI-T7t Kanr marker used in this study, Michael Norgard for his helpful discussions, and Laura Broederdorf for her experimental contribution. We also thank Allen Gies at the UAMS Sequencing Core Facility for his technical assistance.

This research was supported by funding to Jon S. Blevins from the NIH/NIAID (R01AI087678) and the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000.

Footnotes

Published ahead of print 27 April 2012

REFERENCES

  • 1. Anguita J, et al. 2000. Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Infect. Immun. 68:1222–1230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Beck LL, Smith TG, Hoover TR. 2007. Look, no hands! Unconventional transcriptional activators in bacteria. Trends Microbiol. 15:530–537 [DOI] [PubMed] [Google Scholar]
  • 3. Blevins JS, Hagman KE, Norgard MV. 2008. Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol. 8:82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Blevins JS, Revel AT, Smith AH, Bachlani GN, Norgard MV. 2007. Adaptation of a luciferase gene reporter and lac expression system to Borrelia burgdorferi. Appl. Environ. Microbiol. 73:1501–1513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Blevins JS, et al. 2009. Rrp2, a σ54-dependent transcriptional activator of Borrelia burgdorferi, activates rpoS in an enhancer-independent manner. J. Bacteriol. 191:2902–2905 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Boardman BK, et al. 2008. Essential role of the response regulator Rrp2 in the infectious cycle of Borrelia burgdorferi. Infect. Immun. 76:3844–3853 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Brahmachary P, Dashti MG, Olson JW, Hoover TR. 2004. Helicobacter pylori FlgR is an enhancer-independent activator of σ54-RNA polymerase holoenzyme. J. Bacteriol. 186:4535–4542 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Buck M, Gallegos MT, Studholme DJ, Guo Y, Gralla JD. 2000. The bacterial enhancer-dependent σ54N) transcription factor. J. Bacteriol. 182:4129–4136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Burtnick MN, et al. 2007. Insights into the complex regulation of rpoS in Borrelia burgdorferi. Mol. Microbiol. 65:277–293 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Caimano MJ, Eggers CH, Gonzalez CA, Radolf JD. 2005. Alternate sigma factor RpoS is required for the in vivo-specific repression of Borrelia burgdorferi plasmid lp54-borne ospA and lp6.6 genes. J. Bacteriol. 187:7845–7852 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Caimano MJ, et al. 2007. Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle. Mol. Microbiol. 65:1193–1217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Caimano MJ, et al. 2011. The hybrid histidine kinase Hk1 is part of a two-component system that is essential for survival of Borrelia burgdorferi in feeding Ixodes scapularis ticks. Infect. Immun. 79:3117–3130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. de Silva AM, Fikrig E. 1997. Arthropod- and host-specific gene expression by Borrelia burgdorferi. J. Clin. Investig. 99:377–379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. de Silva AM, Telford SR, III, Brunet LR, Barthold SW, Fikrig E. 1996. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183:271–275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Eggers CH, Caimano MJ, Radolf JD. 2004. Analysis of promoter elements involved in the transcriptional initiation of RpoS-dependent Borrelia burgdorferi genes. J. Bacteriol. 186:7390–7402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Fisher MA, et al. 2005. Borrelia burgdorferi σ54 is required for mammalian infection and vector transmission but not for tick colonization. Proc. Natl. Acad. Sci. U. S. A. 102:5162–5167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Fraser CM, et al. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580–586 [DOI] [PubMed] [Google Scholar]
  • 18. Gilmore RD, Jr, Mbow ML, Stevenson B. 2001. Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis. Microbes Infect. 3:799–808 [DOI] [PubMed] [Google Scholar]
  • 19. He M, et al. 2011. Cyclic di-GMP is essential for the survival of the Lyme disease spirochete in ticks. PLoS Pathog. 7:e1002133 doi:10.1371/journal.ppat.1002133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Hubner A, et al. 2001. Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc. Natl. Acad. Sci. U. S. A. 98:12724–12729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Hughes CA, Kodner CB, Johnson RC. 1992. DNA analysis of Borrelia burgdorferi NCH-1, the first northcentral U.S. human Lyme disease isolate. J. Clin. Microbiol. 30:698–703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Joslin SN, Hendrixson DR. 2008. Analysis of the Campylobacter jejuni FlgR response regulator suggests integration of diverse mechanisms to activate an NtrC-like protein. J. Bacteriol. 190:2422–2433 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Keseler IM, Kaiser D. 1997. σ54, a vital protein for Myxococcus xanthus. Proc. Natl. Acad. Sci. U. S. A. 94:1979–1984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Kostick JL, et al. 2011. The diguanylate cyclase, Rrp1, regulates critical steps in the enzootic cycle of the Lyme disease spirochetes. Mol. Microbiol. 81:219–231 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Liang FT, et al. 2010. BB0250 of Borrelia burgdorferi is a conserved and essential inner membrane protein required for cell division. J. Bacteriol. 192:6105–6115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Morett E, Segovia L. 1993. The σ54 bacterial enhancer-binding protein family: mechanism of action and phylogenetic relationship of their functional domains. J. Bacteriol. 175:6067–6074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Ohnishi J, Piesman J, de Silva AM. 2001. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc. Natl. Acad. Sci. U. S. A. 98:670–675 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Ouyang Z, Blevins JS, Norgard MV. 2008. Transcriptional interplay among the regulators Rrp2, RpoN and RpoS in Borrelia burgdorferi. Microbiology 154:2641–2658 [DOI] [PubMed] [Google Scholar]
  • 29. Pollack RJ, Telford SR, III, Spielman A. 1993. Standardization of medium for culturing Lyme disease spirochetes. J. Clin. Microbiol. 31:1251–1255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Ramamoorthy R, Philipp MT. 1998. Differential expression of Borrelia burgdorferi proteins during growth in vitro. Infect. Immun. 66:5119–5124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Rappas M, Bose D, Zhang X. 2007. Bacterial enhancer-binding proteins: unlocking σ54-dependent gene transcription. Curr. Opin. Struct. Biol. 17:110–116 [DOI] [PubMed] [Google Scholar]
  • 32. Rogers EA, et al. 2009. Rrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions. Mol. Microbiol. 71:1551–1573 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Schwan TG, Piesman J. 2000. Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J. Clin. Microbiol. 38:382–388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. U. S. A. 92:2909–2913 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Smith AH, Blevins JS, Bachlani GN, Yang XF, Norgard MV. 2007. Evidence that RpoS (σS) in Borrelia burgdorferi is controlled directly by RpoN (σ54N). J. Bacteriol. 189:2139–2144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Steere AC. 2001. Lyme disease. N. Engl. J. Med. 345:115–125 [DOI] [PubMed] [Google Scholar]
  • 37. Studholme DJ, Buck M. 2000. The biology of enhancer-dependent transcriptional regulation in bacteria: insights from genome sequences. FEMS Microbiol. Lett. 186:1–9 [DOI] [PubMed] [Google Scholar]
  • 38. Suk K, et al. 1995. Borrelia burgdorferi genes selectively expressed in the infected host. Proc. Natl. Acad. Sci. U. S. A. 92:4269–4273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Xu H, et al. 2010. Role of acetyl-phosphate in activation of the Rrp2-RpoN-RpoS pathway in Borrelia burgdorferi. PLoS Pathog. 6:e1001104 doi:10.1371/journal.ppat.1001104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Yang X, et al. 2000. Interdependence of environmental factors influencing reciprocal patterns of gene expression in virulent Borrelia burgdorferi. Mol. Microbiol. 37:1470–1479 [DOI] [PubMed] [Google Scholar]
  • 41. Yang XF, Alani SM, Norgard MV. 2003. The response regulator Rrp2 is essential for the expression of major membrane lipoproteins in Borrelia burgdorferi. Proc. Natl. Acad. Sci. U. S. A. 100:11001–11006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Yang XF, et al. 2005. Analysis of the ospC regulatory element controlled by the RpoN-RpoS regulatory pathway in Borrelia burgdorferi. J. Bacteriol. 187:4822–4829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Yang XF, Pal U, Alani SM, Fikrig E, Norgard MV. 2004. Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J. Exp. Med. 199:641–648 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES